div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: jataorjp · 76 and safety of pyramnamide—cantaining intensified short—course regimen with those of standard regimen without pyrazinamide Sputum negative conversion rates after src=https:reader030fdocumentsnetreader030viewer20220407005d56e47688c9939d368bbac1html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: jataorjp · 76 and safety of pyramnamide—cantaining intensified short—course regimen with those of standard regimen without pyrazinamide Sputum negative conversion rates after src=https:reader030fdocumentsnetreader030viewer20220407005d56e47688c9939d368bbac1html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: jataorjp · 76 and safety of pyramnamide—cantaining intensified short—course regimen with those of standard regimen without pyrazinamide Sputum negative conversion rates after src=https:reader030fdocumentsnetreader030viewer20220407005d56e47688c9939d368bbac1html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: jataorjp · 76 and safety of pyramnamide—cantaining intensified short—course regimen with those of standard regimen without pyrazinamide Sputum negative conversion rates after src=https:reader030fdocumentsnetreader030viewer20220407005d56e47688c9939d368bbac1html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: jataorjp · 76 and safety of pyramnamide—cantaining intensified short—course regimen with those of standard regimen without pyrazinamide Sputum negative...